Medication info
Lozatap Tablets 100 mg (Losartan Potassium)

Lozatap Tablets 100 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
White drop-shaped film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201603792 · Approved 2016.06.22

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations No adjustment of the initial dose is required in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years of age and older weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to treat hypertension, particularly helping to prevent and treat kidney disease related to hypertension in patients with type 2 diabetes. It effectively lowers blood pressure, reducing the burden on the cardiovascular system and contributing to the protection of kidney function. Therefore, it plays an important role in blood pressure management and kidney health improvement.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations No adjustment of the initial dose is required in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years of age and older weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, and should not be used by women who are pregnant or may become pregnant. If pregnancy is confirmed, the use of this medication should be discontinued immediately, and tests to check the health status of the fetus are necessary. Patients with severely impaired liver function or certain genetic diseases should not take this medication, and elderly patients or those with weak kidney function should use it with caution. Since this medication lowers blood pressure, symptoms of low blood pressure or renal failure may occur; if symptoms arise, medical consultation should be sought immediately. Due to the possibility of hyperkalemia, it is advisable to regularly check potassium levels and not to take potassium supplements or medications containing potassium together with this drug. During treatment with this medication, symptoms such as dizziness or drowsiness may occur, so caution should be exercised when driving or operating machinery. Interactions may occur when taken with other antihypertensive agents, diuretics, or non-steroidal anti-inflammatory drugs (NSAIDs), so it is essential to inform the physician. This medication is not recommended for use in pediatric patients or children under 6 years of age, as safety and efficacy have not been established. In case of overdose, symptoms such as low blood pressure and decreased heart rate may appear, and immediate medical attention should be sought for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to other containers for safety.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 127 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effects
  • fainting
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • neural hypersensitivity
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorders
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nosebleed
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation in the eyes
  • pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urinary tract infection
  • angioedema
  • vasculitis
  • anaphylactoid syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • myalgia
  • weakness
  • increased creatine kinase
  • rhabdomyolysis
  • dry cough
  • erythema multiforme
  • hyponatremia
  • increased ALT
  • fainting
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopy
  • hypoglycemia
  • shock symptoms due to hypotension
  • loss of consciousness due to hypotension
  • dyspnea due to hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. Additionally, it is recommended to store it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White drop-shaped film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.